Association between apolipoprotein B gene polymorphisms and the risk of coronary heart disease (CHD) : an update meta-analysis
Zhang, J-Zhan.; Zheng, Y-Ying.; Yang, Y-Ning.; Li, X-Mei.; Fu, Z-Yan.; Dai, C-Fang.; Liu, F.; Chen, B-Dang.; Gai, M-Tao.; Ma, Y-Tong.; Xie, X.
Journal of the renin-angiotensin-aldosterone system JRAAS 16(4): 827-837
2015
ISSN/ISBN: 1470-3203 PMID: 26537298 DOI: 10.1177/1470320315615047
Accession: 057249319
Polymorphisms in the apolipoprotein B (apoB) gene have been reported to be associated with coronary heart disease (CHD). However, the results on this topic are conflicting. The present study aims to derive a more precise estimation of the relationship between CHD and apoB genetic polymorphisms by meta-analysis. We identified a total of 54 studies involving 7236, 10,912, and 14,102 individuals, respectively, for EcoRI, XbaI, and SpIns/Del polymorphisms by searching in PubMed, Web of Science, Google Scholar, the Cochrane Library, Wanfang Data, SinoMed, and CNKI. We utilized RevMan 5.0 software to perform the meta-analyses. A significant statistical association between apoB EcoRI polymorphism and CHD was observed under an allelic (p = 0.001, odds ratio (OR) = 1.33, 95% confidence interval (CI) = 1.12-1.57), dominant (p = 0.005, OR = 1.22, 95% CI = 1.06-1.40), and recessive (p = 0.04, OR = 1.33, 95% CI = 1.01-1.74) model. We also found similar association of apoB SpIns/Del polymorphism with CHD. However, we did not find association between apoB XbaI polymorphism and CHD. The current meta-analysis found an association of EcoRI polymorphism and SpIns/Del polymorphism with an increased risk of CHD. No significant association between apoB XbaI polymorphism and CHD we observed in the present study.